Anhui Huaren Health Pharmaceutical Co., Ltd. Share Price
Equities
301408
CNE100005YT4
Drug Retailers
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.79 CNY | +1.03% | +2.16% | -19.81% |
Sales 2022 | 3.26B 451M 37.65B | Sales 2023 | 3.8B 525M 43.82B | Capitalization | 6.38B 882M 73.62B |
---|---|---|---|---|---|
Net income 2022 | 161M 22.26M 1.86B | Net income 2023 | 115M 15.9M 1.33B | EV / Sales 2022 * | - |
Net Debt 2022 | 280M 38.7M 3.23B | Net Debt 2023 | 32.87M 4.54M 379M | EV / Sales 2023 | 1.69 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
55
x | Employees | 6,873 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 17.24% |
1 day | +1.03% | ||
1 week | +2.16% | ||
Current month | +2.16% | ||
1 month | +11.61% | ||
3 months | +14.91% | ||
6 months | -27.98% | ||
Current year | -19.81% |
Managers | Title | Age | Since |
---|---|---|---|
Jia Le He
CEO | Chief Executive Officer | 48 | 01/08/01 |
Hai Li
DFI | Director of Finance/CFO | 47 | 01/18/01 |
Jun Yin
BRD | Director/Board Member | 44 | 01/08/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xue Min Zhou
BRD | Director/Board Member | 59 | 01/19/01 |
Zhi Ying Liu
BRD | Director/Board Member | 60 | 01/19/01 |
Xu Lu
BRD | Director/Board Member | 46 | 01/18/01 |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 12.79 | +1.03% | 5 894 155 |
10/24/10 | 12.66 | -2.16% | 2,915,200 |
09/24/09 | 12.94 | +1.41% | 3,184,963 |
08/24/08 | 12.76 | -0.31% | 3,147,200 |
07/24/07 | 12.8 | +0.71% | 2,852,175 |
End-of-day quote Shenzhen S.E., May 13, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-19.81% | 701M | |
-22.12% | 12.04B | |
-24.76% | 6.52B | |
+15.41% | 6.44B | |
-9.27% | 6.15B | |
-2.48% | 4.63B | |
+60.00% | 4.62B | |
-6.55% | 3.93B | |
-10.60% | 3.49B | |
-6.69% | 3.05B |
- Stock Market
- Equities
- 301408 Stock